Abstract
Retrospective studies have suggested that patients with a low transvalvular gradient in the presence of an aortic valve area <1.0 cm² and normal ejection fraction may represent a subgroup with an advanced stage of aortic valve disease, reduced stroke volume, and poor prognosis requiring early surgery. We therefore evaluated the outcome of patients with low-gradient "severe" stenosis (defined as aortic valve area <1.0 cm² and mean gradient ≤ 40 mm Hg) in the prospective Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Circulation (Baltimore) |
| Vol/bind | 123 |
| Udgave nummer | 8 |
| Sider (fra-til) | 887-95 |
| Antal sider | 9 |
| ISSN | 0009-7322 |
| DOI | |
| Status | Udgivet - 1 mar. 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS